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Summary: A procedure is described for the determination of the following 19 metabolites in 200 mg gastro-
cnemius muscle from guinea pig: glucose, glucose 1-phosphate and orphosphate, fructose 6-phosphate, fruc-
tose 1,6-bisphosphate, glyceraldehyde 3-phosphate, dihydroxyacetone phosphate, 3-phospho- and 2-phos-
phoglyceric acid, phosphoenolpyruvate, pyruvate, glycerol, glycerol 3-phosphate, AMP, ADP, ATP, inorgan-
ic phosphate, creatine, creatine phosphate. Bioluminometric and fluorometric techniques for mono- and di-
nucleotide determinations were used. In the case of fluorometric measurement of NADH, 400 mg tissue were
necessary. The coefficient of Variation for assays on the same sample was 0.04 for bioluminometric techniques
and 0.10 for fluorometric techniques.
Bioluminometrische und fluorometrische Methoden zur Konzentrationsbestimmung von 19 Metabo Uten
AD P/ATP-abhängiger Umsätze des Energiestoffwechsels in 200 (oder 400) mg Muskel
Zusammenfassung: Es wird eine Methodik zur Konzentrationsbestimmung der folgenden 19 Metaboliten in
200 mg m. gastrocnemiüs des Meerschweinchen beschrieben:
Glucose, Glucose- 1-phosphat und -6-phosphat, Fructose-6-phosphat, Fructose-1,6-bisphosphat, Glycerinal-
dehyd-3-phosphat, Dihydroxyacetonphosphat, 3-Phosphoglycerat, 2-Phosphoglycerat, Phosphoenolpyruvat,
Pyruvat, Glycerin, Glycerin-3-phosphat, AMP, ADP, ATP, anorganisches Phosphat, Kreatin, Kreatinphos-
phat.
Dazu wurden bioluminometrische sowie fluorometrische Methoden angewandt. Falls NADH fluorometrisch
bestimmt wurde, wurden 400 mg Gewebe benötigt. Der Variabilitätskoeffizient bei der Bestimmung einer
und derselben Probe betrüg 0,04 bei der bioluminometrischen und 0,10 bei der fluorometrischen Methodik.
fntroduction
A knowiedge of the concentrations of metabolites in
tissues permits an assessment of the state of metabo-
lism. In previous publications (l, 2)* we demonstrat-
ed, by using certain criteria, that tissue concentra-
tions of rat liver metabolites are rieh sources of in-
formation concerning
(a) an eventual equilibrium state of the transforma-
tions implicating these metabolites,
(b) cosubstrate compartition, and
(c) stoichiometric relations between metabolite
turnover in different cell compartments; this was
true despite the fact that the metabolites may be
compartmentalized within the cell. It was there-
by shown in particular that tissue Substrate con-
centrations of liver metabolites allow the met-
abolic Status to be characterized under several
physiological conditions (alloxan-diabetic,
starved rats and rats fed on carbohydrate or fat
diets).
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With a view to applying these same criteria of Inter-
pretation for cell metabolite concentrations to gui-
nea pig gastrocnemius muscle, we have optimized
determination methods for 16 phosphorylated and
non-phosphorylated metabolites of energy metabo-
lism. The limited sample material and the great
number of assays created a requirement for high sen-
sitivity; this was achieved with fluorometric meth-
ods, and especially by the use of bioluminescence for
the assay of NADH and ATP, ADP and AMP. We
could demonstrate that this method satisfies the pre-
cision requirements for determining metabolite con-
centrations in muscles.
Materials and Methods
M e t a b o l i t e s
Metabolite determinations were carried out s NADH or
NADPH end point conversions vvhich were then measured fluoro-
metrically or by bacterial bioluminescence. The present procedure
was derived from methods in the literature (3) with the aim of
determining if possible several metabolites in one assay; it was
optimized for determinations in muscle extracts. Two tris buffer
Solutions at different pH values were used: 0.30 mol-Γ 1 (final
concentration in the assay) tris(hydroxymethyl)-aminomethane
(tris) adjusted with HC1 to pH = 7.0 or 8.0 containing 5.9
m m o l - Γ 1 MgCl· and 0.5 mmol· Γ ι ethylenediaminetetraacetic
acid (EDTA).
The following assays were carried out in tris buffer at pH = 7.0:
a) 2-phosphoglyceric acid, 3-phosphoglyceric acid and phospho-
enolpyruvate were determined in the presence of 0.76
mmol · l'1 ADP, 0.21 mmol · Γ1 NADH and L-lactate dehy-
drogenase (EC 1.1.1.27; 1.1 umol · min'1), by starting the in-
dividual reactions by addition of pyruvate kinase (EC
2.7.1.40; 0.80 μπιοί-min"1), enolase (EC 4.2.1.11; 0.080
μιτιοί · min"1) and phosphoglycerate mutase (EC 2.7.5.3; 2.5
μπιοί · min"1), in that order.
b) dihydroxyacelone phosphate, glyceraldehyde 3-phosphate, and
pyruvate in the presence of 0.15 mmol · l"1 NADH, by starting
the individual reactions by addition of glycerol 3-phosphate
dehydrogenase (EC 1.1.1.8; 0.14 umol · min"1), triose phos-
phate isomerase (EC 5.3.1.1; 4.0 μιτιοί · min"1) and L-lactate
dehydrogenase (1.1 μπιοί-min"1), in that order.
c) D-fruaose l ,6-bisphosphaie was assayed in the same reaction
solution of b) but with the extra addition of glycerol 3-phos-
phate dehydrogenase (0.14 μιηοίτηίη"1) s well s triose-
phosphate isomerase (4.0 μπιοί · min"1), and by starting the
assay by addition of aldolase (EC 4.1.2.13; 0.09
μιτιοί · min"1).
d) glycerol was determined in the presence of 2.1 mmol-l" 1
ATP, 1.4 mmol-l"1 phosphoenolpyruvate, 0.21 m m o l - Γ 1
NADH, L-lactate dehydrogenase (1.1 μηιοί · min"1) and pyr-
uvate kinase (0.80 μπιοί · min~ l), and the assay was started by
addition of glycerol kinase (EC 2.7.1.30; 0.034 μπιοί · min"1).
e) The assay mixture for creatine was the same s that for glycer-
ol, but the assay was started by addition of creatine kinase (EC
2.7.3.2; 7.6 μπΊΟΙτηπΓ1).
Assays for the following metabolites were carried out in tris
buffer at pH = 8.0:
f) D-glucose 6-phosphate, D-glucose 1-phosphate, fmctose 6-
phosphale in the presence of 6.0 μπιοί-l"1 glucose 1,6-bis-
phosphate and of 1.5 mmol · l"1 NADP by starting the reac-
tions with glucose 6-phosphate dehydrogenase (EC 1.1.1*49;
0.056 μιτιοί-min"1), phosphoglucomutase (EC 2.7.5.1; 0.16
μιτιοί · min"1) and phosphoglucose isomerase (EC 5.3.1.9;
0.28 μηηοΐ · min"1) in that order.
g) D-glucose in the presence of 0.70 mmol-l"1 ATP, 1.5
mmol · Γ1 NADP and D-glucose 6-phosphate dehydrogenase
(0.056 μπιοί· min"1) by starting the assayf with hexokinase
(EC 2.7.1.1; 0.28 μιηοΐ - min"1).
A further buffer solution (0.20 fnol · Γ1 imidazole adjusted
with HC1 to pH = 7.0; 0.60 mmol · l~ l MgCl2, 1.0 mmol · Γι
EDTA) was used for:
h) inorganic phosphate assay and contained 6.0 μιτιοί · Γ1 £>-glur
cose 1,6-bisphosphate, 4.9 mmol -Γ 1 glycogen ( s glucosyl
unit), 10 μπιοΙ-Γ1 AMP, 0.50 mmoi · l"1 D,L-dithiothreitol
and 1.5 mmol-l""1 NADP, glucose o^phosphate dehydroge-
nase (0.056 μπιοί · min"1) and phosphoglucomutase (0.16
μπιοί · min"1). The reaction was started with phosphorylase a
(EC 2.4.1.1; 0.20 μπιοί-min"1).
Enzymes for assays f) and h) were dialysed against the buffer
solution for the corresporidiiig assay.
For fluorimetric determinations, the total assay volume amounted
to 145 μΐ, of which 120 μΐ were neutralized tissue extract and the
remainder consisted of reagent and buffer mix. Enzymes for start-
ing the reactions were added in sample tubes (3.0 mm inner di-
ameter) made of selected optical glass (Hellma, M llheim, Baden,
Germany). The higher sensitivity of the bioluminescent determi-
nation allowed 20 μΐ tissue extract to be used.
All biochemicals were purchased frorn Boehringer, Mannheim,
Germany; all chemicals frorn Merck, Darmstadt, Germany.
The tissue extracts were prepared by pulverizing one portjon of
frozen tissue and two portions of 0.60 mol · l"1 HC1O4 with 0.10
mmol · l"1 EDTA at the presence of liquid nitrogen in a pulveriz-
er (Pulverisette, Pritsche, Idar-Oberstein, Germany). The thawed
powder was centrifuged for 20 min at about l O5 g; the supernatant
was neutralized with 2 rnol · Γ1 KaCOs, centrifuged for 2 min s
above and in part appropriately diluted for the assays. The sarn^
ples in the different assays consisted of Solutions of the neutralized
tissue extract correspondingly diluted: l : l for b) and f); l : 2 for
a); l : 3 for c); l : 5 for d); t : 10 for g); L: 20 for h) and l : 100
for the creatine assay (e).
Bioluminescence determinations of NADH concentration in the
assay and in the blanks were carried out after dilution (l: 100 or
lower) and mixing 10.0 ul with 50.0 ul reconstituted NADH-mon-
itoring reagent (LKB-Wallac, Turku, Finland) and 200 μ] 0.100
mol · l"1 potassium phosphate buffer at pH = 7.00; the constant
luminescence was measured in a 1251 Luminometer (LKB). In
this same sample tube, 10.0 μΐ 0.5 μπιοί -Γ1 NADH s interna'l
Standard were added twice; the luminescence was registered after
every addition and the NADH-concentration calculated accord-
ing to Feraudi et al. (4). The recovery ratio of NADH s an effect
of metabolite conversion varied in the different assays a)—e). This
ratio was therefore determined by addition pf a metabolite Stand-
ard to the assay (cf. I.e. (4)).
Calibration for direct fluorometric measurement of NAD(P)H
concentrations in the assays was carried out by using a N AD(P)H
sample s control before every measurement to correct light
source inconstancy. A calibration curve for the NADH or
NADPH fluorescence versus the concentration in the sarne assay
solution was approxiitiated with a polynome quotient (for algo-
rithrris see I.e. (5)). The sample concentration was then calculated
from its fluorescence val e. The eoefficient of Variation for the
same sample amounted to 0.10, whereas in the bioluminescent
method it amounted to 0.04.
i) AMP, ADP and A TP were determined according to Feraudi et
al. (4); because of interferences from metabolites in the mus-
cle 'extract, the recovery ratio for these adenine mononucleo-
tides was specially determined for these samples and remained
constant among them. ' *
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j) Creatine phosphate was determined bioluminescently after its
conversion to ATP. 50.0 μΐ neutralized and diluted muscle ex-
tract which contained about 5 nmol creatine phosphate were
mixcd in micro test tubes with 50.0 μΐ 2.5 mmol · l"' ADP and
144μ1 of fhe following mixture:
1.44ml 0.10 mol - Γ 1 tris adjusted lo pH = 7.75 with acetic
acid and 20 μΐ crcatine kinase solution (EC 2.7.3.2;
l mg · ml"1, Boehringer, 25 U/mg protein). The closed tubes
werc incubated for 30 min at 37 °C. The reaction solution was
diluted (l : l O4) and used for ATP determination according to
i) (see above). An internal Standard with creatine phosphate
was also analysed for every sample to determine the recovery
ratio.
A n i m a I s
The male guinea pigs used for the present metabolite determina-
tions were the same s those in a previous study (6).
Calcu la t ions
Calculations were performed by means of a Computer Commo-
dore 3032 with printer 3022.
The coefficients of Variation (CV) are given s CV = S.D.
Results
The recovery of each metabolite to be measured was
calculated for fluorometric and bioluminescent met-
abolite determinations, using photometric calibra-
tion and assay mixtures of the composition given in
the methods. Within the limits of experimental error,
this recovery ratio was unity for fluorometry. Lumi-
nometric determinations allowed the measurement
of recovery ratios different from unity. These recov-
eries were taken into consideration in the concentra-
tion Calculations. With respect to recovery, simil r
behaviour was observed in the bioluminescent deter-
mination of AMP, ADP and ATP (4). Creatine
phosphate was determined by means of an internal
creatine phosphate Standard.
Taking into account the above factors in calculating
metabolite concentrations, we obtained the results
shown in table l for gastrocnemius muscle of un-
treated guinea pig. Because of the Singular feature of
the results, i.e. that the large coefficient of Variation
(up to 0.56) of some metabolite concentrations con-
trasts with the reproducibility of the method, mean
values may not describe the collective. A.concentra-
tion of 10 μηιοί · kg ' can still be rneasured with a
coefficient of Variation around 0.3. The question s
to whether the broad distribution of the concentra-
* tion values may be explained s an expression of the
laws regulating muscle cell metabolism can be ans-
wered s follows: In recent studies (1,2), we demon-
strated that cell concentrations of metabolites in the
liver allow constant relationships to be found be-
tween mass ratios of transformations which concern
them. Consider the transformation from glycerate 2-
phosphate to glycerate 3-phosphate:
The cprresponding mass ratio glycerate 3-phos-
' phate/glycerate 2-phosphate in table l shows a low-
er coefficient of Variation (0.33) than that expected
from the coefficients of Variation of glycerate 3-
phosphate and glycerate 2-phosphate (0.36 and 0.30
respectively). The mean 5.59 matches well with the
equilibrium constant value 5.0 (7). Lower coeffi-
cients of Variation (CV) were also found for the fol-
lowing mass quotients:
fructose 1,6-bisphosphate / [dihydroxyacetone phos-
phate x glyderaldehyde 3-phosphate] (CV = 0.24);
fructose 1,6-bisphosphate χ pyruvate / [fructose 6-
phosphate χ phosphoenolpyruvate] (CV = 0.08);
glycerol x glucose 6-phosphate / [glycerol 3-phos-
phate x glucose] (CV = 0.28);
glucose 6-phosphate x creatine / [glucose x creatine
phosphate] (CV = 0.51);
glucose 6-phosphate x pyruvate / [glucose x phos-
phoenolpyruvate] (CV = 0.24).
Also the energy Charge (ATP + 0.5 ADP)/
(ATP + ADP -h AMP) shows a lower CV (0.09)
than that expected. Besides glucose l-phosphate and
inorganic phosphate, all metabolites measured here
seem to obey to relationships in which the mass rati-
os or energy Charge may have nearly constant values.
Simil r results were also found for trained guinea
pigs (Feraudi et al. in preparation). The low CV of
the quotients above demonstrate that the single con-
centrations involved were determined precisely
enough arid that the broad scatter of values is to be
attributed to the nature of interdependence relation-
ships between muscle metabolite concentrations.
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